CPT 79403 Radiolabeled Antibody Infusion Reimbursement | OpenPayer

Summary & Overview

CPT 79403: Radiolabeled Monoclonal Antibody Intravenous Infusion

CPT code 79403 denotes the intravenous infusion of radiolabeled monoclonal antibodies for therapeutic purposes. This code captures a specialized oncology procedure that combines biologic therapy with targeted radiotherapy, supporting treatment regimens for selected malignancies and certain systemic conditions where radioimmunotherapy is indicated. Nationally, accurate coding for this service matters for clinical documentation, care coordination, and payer adjudication given the high-cost, high-complexity nature of radiolabeled biologic infusions.

Key payers referenced include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication presents the clinical context for CPT code 79403, typical sites of care, and the common billing modifiers associated with infusion services. Readers will find concise benchmarks for coding and billing practices, an outline of payer coverage considerations, and an overview of operational implications for infusion centers and oncology clinics. The content is intended to help billing managers, clinicians, and policy analysts understand where this code fits within therapeutic oncology services and what issues commonly arise during claims submission and payer review.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareCPT 79403radiolabeled monoclonal antibodyinfusion therapyoncology infusionradioimmunotherapytherapeutic infusionhospital outpatientbilling and coding

Billing Code Overview

CPT code 79403 describes the infusion of radiolabeled monoclonal antibodies administered directly into the venous bloodstream to treat the patient’s condition. This service is a therapeutic infusion of a radiolabeled biologic agent designed to deliver targeted radiation to disease sites.

Service type: Therapeutic radiolabeled monoclonal antibody infusion
Typical site of service: Hospital outpatient infusion center or specialized oncology infusion clinic

Clinical & Coding Specifications

Clinical Context

A typical patient is a 62-year-old with metastatic colorectal carcinoma who presents for systemic radiolabeled monoclonal antibody infusion to target circulating or metastatic tumor cells. The patient has completed prior staging and interdisciplinary tumor board review confirming suitability for radiolabeled antibody therapy. On the day of service the patient arrives to an outpatient oncology infusion center or hospital outpatient infusion suite. Pre-infusion steps include verification of identity, review of recent labs (complete blood count, renal and hepatic function), assessment for active infections or pregnancy, informed consent, and confirmation of appropriate radiopharmaceutical dose prepared by nuclear pharmacy and radiopharmacist. Vascular access is established via a peripheral IV or implanted central venous access device. The nuclear medicine physician or authorized oncology specialist performs time-out procedures, confirms radiolabel and activity, and supervises administration while nursing monitors vital signs, radiation safety protocols, and infusion pump function. Post-infusion observation for immediate hypersensitivity or infusion-related adverse events occurs in the same infusion setting; radiation safety and patient discharge instructions are provided, including precautions for bodily fluids and follow-up imaging or laboratory surveillance scheduled by the treating team. Typical sites of service are an outpatient hospital infusion center, freestanding oncology infusion clinic, or ambulatory nuclear medicine department.

Coding Specifications

Modifier	Description	When to Use
`25`	Data not available in the input.

CPT 79445: Transarterial Radioembolization with Intra-arterial Radioactive Injection

CPT-79999-RADIOPHARMACEUTICAL-THERAPY-UNLISTED-PROCEDURE

CPT 79999: Unlisted Radiopharmaceutical Therapy Procedure

CPT-79005-ORAL-RADIOPHARMACEUTICAL-THERAPY

CPT 79005: Oral Radiopharmaceutical Administration for Therapy

CPT-79440-RADIOPHARMACEUTICAL-INJECTION-FOR-SYNOVIAL-INFLAMMATION

CPT 79440: Radiopharmaceutical Joint Injection for Synovial Inflammation

CPT-79200-INTRACAVITARY-RADIOPHARMACEUTICAL-ADMINISTRATION

CPT 79200: Intracavitary Radiopharmaceutical Administration

CPT-79300-INTERSTITIAL-BRACHYTHERAPY-IMPLANTATION

CPT 79300: Interstitial Brachytherapy Implantation

CPT-79101-RADIOPHARMACEUTICAL-INTRAVENOUS-THERAPY

CPT 79101: Intravenous Radiopharmaceutical Therapeutic Injection

Taxonomy Code	Specialty	Notes
`2086S0002X`	Medical Oncology	Physicians who prescribe and supervise systemic oncologic therapies, commonly order and oversee radiolabeled antibody infusions.
`207RH0000X`	Radiation Oncology	Specialists involved in planning and oversight of radiotherapeutic agents including radiolabeled antibodies.
`334P00000X`	Nuclear Medicine	Physicians who handle radiopharmaceutical preparation, prescribing, and administration oversight.
`363A00000X`	Nurse Practitioner	Advanced practice providers who may manage infusion visits and monitoring in oncology settings.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C78.7`	Secondary malignant neoplasm of liver and intrahepatic bile duct	Common site of metastasis for cancers treated with systemic radiolabeled monoclonal antibody therapy.
`C78.6`	Secondary malignant neoplasm of retroperitoneum and peritoneum	Represents metastatic disease sites potentially targeted by systemic radiolabeled antibodies.
`C79.9`	Secondary malignant neoplasm of unspecified site	Used when metastatic disease is present but specific site coding is not available and systemic radiolabeled therapy is indicated.
`C18.9`	Malignant neoplasm of colon, unspecified	Primary malignancy often treated with systemic biologic and radiolabeled antibody therapies in metastatic settings.
`C50.919`	Malignant neoplasm of unspecified site of right female breast	Breast cancer can be an indication for targeted radiolabeled antibody therapy in select metastatic or refractory cases.
`D49.1`	Neoplasm of uncertain behavior of lymph nodes	May be used in workup scenarios where targeted radiolabeled antibodies are considered for diagnostic or therapeutic purposes.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96365`	Intravenous infusion, therapeutic, prophylactic, or diagnostic; initial, up to 1 hour	May be used for documenting the actual infusion time for adjunctive intravenous medications given during the radiolabeled antibody visit (e.g., premedication or hydration).
`96413`	Chemotherapy administration, IV infusion technique; each additional hour	Used when additional monitored infusion time is billed for concurrent chemotherapeutic or biologic infusions administered during the same encounter.
`36415`	Collection of venous blood by venipuncture	Performed for pre-infusion laboratory testing (CBC, chemistries) documented as part of the treatment visit.
`77012`	Fluoroscopic guidance for vascular access; radiological supervision and interpretation	May be performed if image-guided central catheter placement is required prior to infusion.
`A9513`	Sodium iodide I-131 therapeutic, per millicurie (CMS-assigned HCPCS)	Example of a radiotherapeutic product code used for billing radiopharmaceuticals; relates to the radiolabeled agent component of therapy.

OpenPayer